Gene and cell therapies hold the potential to revolutionize medicine by fighting rare, life-threatening and – until now - uncurable diseases for which no other treatments are available.
For instance, these therapies are capable of restoring normal gene or cell activity, for genetic disease treatment. Viral vectors are commonly used to deliver the engineered genetic payload to in situ diseased cells and / or to ex vivo cells.
The development of gene and cell therapies is held back by considerable manufacturing and safety challenges. These limitations contribute to the high costs of many gene and cell therapies.
NewBiologix is committed to increase the safety and to allow economically viable large-scale production of viral vectors for gene therapies.
We are working to create innovative solutions that harness the power of cells to treat a range of diseases and conditions.
Our engineered cell line is designed to produce high-level and safe drugs (AAV) for gene therapy.
Leveraging NGS technology, we revolutionize cell line engineering to create next-gen therapeutic products.